These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9440874)
21. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist. Bernstein DI; Blaiss MS; Cox LS; Finegold I; Lanier BQ; Nelson HS; Wallace DV Ann Allergy Asthma Immunol; 2011 Nov; 107(5):422-5. PubMed ID: 22018613 [No Abstract] [Full Text] [Related]
22. The allergist and the intensivist: not such odd bedfellows. Pillay K; Fung SS; Cohn JR Ann Allergy Asthma Immunol; 2014 Feb; 112(2):94-6. PubMed ID: 24468246 [No Abstract] [Full Text] [Related]
24. [Specific immunotherapy (desensitization)]. Klimek L; Rasp G; Ebner C Wien Med Wochenschr; 1999; 149(14-15):393. PubMed ID: 10584281 [No Abstract] [Full Text] [Related]
25. Regulatory control and standardization of allergenic extracts. Clinical methods of evaluation of extracts. Norman PS Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):65-9. PubMed ID: 6625586 [No Abstract] [Full Text] [Related]
26. How to stop the allergy march. Lopes Dos Santos JM Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107 [No Abstract] [Full Text] [Related]
27. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration. Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411 [TBL] [Abstract][Full Text] [Related]
28. Immunotherapy coming of age: notable advances during the first hundred years. Nelson HS Expert Rev Clin Immunol; 2017 May; 13(5):389-392. PubMed ID: 28443797 [No Abstract] [Full Text] [Related]
30. [Desensitization therapy]. Suomen Allergologi- ja Immunologiyhdistys ry:n asettama työryhmä Duodecim; 2002; 118(12):1302-9. PubMed ID: 12239822 [No Abstract] [Full Text] [Related]
31. Regulatory control and standardization of allergenic extracts. Leading motive: thesis and antithesis. Göing H Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):7-11. PubMed ID: 6625587 [No Abstract] [Full Text] [Related]
32. Some highlights of the first century of immunotherapy. Nelson HS Ann Allergy Asthma Immunol; 2011 Nov; 107(5):417-21. PubMed ID: 22018612 [No Abstract] [Full Text] [Related]
34. THE IMMUNOLOGY OF ALLERGY. BARLOW PP Calif Med; 1964 Aug; 101(2):90-4. PubMed ID: 14180503 [TBL] [Abstract][Full Text] [Related]
35. Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Joint Task Force on Practice Parameters Ann Allergy Asthma Immunol; 2003 Jan; 90(1 Suppl 1):1-40. PubMed ID: 12542071 [No Abstract] [Full Text] [Related]
36. Regulatory control and standardization of allergenic extracts. The clinical trial protocol. Aas K Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):55-63. PubMed ID: 6354091 [No Abstract] [Full Text] [Related]
37. [Allergy to domestic and laboratory animals]. Bousquet J; Guerin B; Michel FB Rev Mal Respir; 1986; 3(1):25-9. PubMed ID: 3715163 [TBL] [Abstract][Full Text] [Related]
38. Influence of mite growth culture phases on the biological standardization of allergenic extracts. Eraso E; Martínez J; García-Ortega P; Martínez A; Palacios R; Cisterna R; Guisantes JA J Investig Allergol Clin Immunol; 1998; 8(4):201-6. PubMed ID: 9777533 [TBL] [Abstract][Full Text] [Related]